» Articles » PMID: 39096350

Phages Produce Persisters

Overview
Date 2024 Aug 3
PMID 39096350
Authors
Affiliations
Soon will be listed here.
Abstract

Arguably, the greatest threat to bacteria is phages. It is often assumed that those bacteria that escape phage infection have mutated or utilized phage-defence systems; however, another possibility is that a subpopulation forms the dormant persister state in a manner similar to that demonstrated for bacterial cells undergoing nutritive, oxidative, and antibiotic stress. Persister cells do not undergo mutation and survive lethal conditions by ceasing growth transiently. Slower growth and dormancy play a key physiological role as they allow host phage defence systems more time to clear the phage infection. Here, we investigated how bacteria survive lytic phage infection by isolating surviving cells from the plaques of T2, T4, and lambda (cI mutant) virulent phages and sequencing their genomes. We found that bacteria in plaques can escape phage attack both by mutation (i.e. become resistant) and without mutation (i.e. become persistent). Specifically, whereas T4-resistant and lambda-resistant bacteria with over a 100,000-fold less sensitivity were isolated from plaques with obvious genetic mutations (e.g. causing mucoidy), cells were also found after T2 infection that undergo no significant mutation, retain wild-type phage sensitivity, and survive lethal doses of antibiotics. Corroborating this, adding T2 phage to persister cells resulted in 137,000-fold more survival compared to that of addition to exponentially growing cells. Furthermore, our results seem general in that phage treatments with Klebsiella pneumonia and Pseudomonas aeruginosa also generated persister cells. Hence, along with resistant strains, bacteria also form persister cells during phage infection.

Citing Articles

Harnessing Bacteriophages for Sustainable Crop Protection in the Face of Climate Change.

Czajkowski R, Roca A, Matilla M Microb Biotechnol. 2025; 18(2):e70108.

PMID: 39937142 PMC: 11816701. DOI: 10.1111/1751-7915.70108.


Microbes Saving Lives and Reducing Suffering.

Timmis K, Karahan Z, Ramos J, Koren O, Perez-Cobas A, Steward K Microb Biotechnol. 2025; 18(1):e70068.

PMID: 39844583 PMC: 11754571. DOI: 10.1111/1751-7915.70068.


Phage biocontrol success of bacterial wilt depends on synergistic interactions with resident rhizosphere microbiota.

Franco Ortega S, Fields B, Narino Rojas D, Mikonranta L, Holmes M, Harper A Microb Biotechnol. 2024; 17(11):e70049.

PMID: 39539110 PMC: 11561305. DOI: 10.1111/1751-7915.70049.


Conformational change as a mechanism for toxin activation in bacterial toxin-antitoxin systems.

Sanchez-Torres V, Hwang H, Wood T J Virol. 2024; 98(11):e0151324.

PMID: 39445801 PMC: 11575165. DOI: 10.1128/jvi.01513-24.

References
1.
Williams M, Reker A, Margolis S, Liao J, Wiedmann M, Rojas E . Restriction endonuclease cleavage of phage DNA enables resuscitation from Cas13-induced bacterial dormancy. Nat Microbiol. 2023; 8(3):400-409. PMC: 9992242. DOI: 10.1038/s41564-022-01318-2. View

2.
Van Goethem M, Marasco R, Hong P, Daffonchio D . The antibiotic crisis: On the search for novel antibiotics and resistance mechanisms. Microb Biotechnol. 2024; 17(3):e14430. PMC: 10926060. DOI: 10.1111/1751-7915.14430. View

3.
Kwan B, Chowdhury N, Wood T . Combatting bacterial infections by killing persister cells with mitomycin C. Environ Microbiol. 2015; 17(11):4406-14. DOI: 10.1111/1462-2920.12873. View

4.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655. PMC: 8841637. DOI: 10.1016/S0140-6736(21)02724-0. View

5.
Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M . Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol. 2006; 2:2006.0008. PMC: 1681482. DOI: 10.1038/msb4100050. View